CD8A and cancer: Beneficial survival effects of universally expressed CD8+ T cell genes in immunotherapy responders were also validated in our LC cohort, indicating common gene expression programs in immunotherapy responders hold prognostic significance even in patients of different cancer types (Supplementary Fig. S19B).